{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:26:11Z","timestamp":1772504771497,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>No case definition of Type 1 diabetes (T1D) for the claims data has been proposed in Japan yet. This study aimed to evaluate the performance of candidate case definitions for T1D using Electronic health care records (EHR) and claims data in a University Hospital in Japan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The EHR and claims data for all the visiting patients in a University Hospital were used. As the candidate case definitions for claims data, we constructed 11 definitions by combinations of International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. (ICD 10) code of T1D, the claims code of insulin needles for T1D patients, basal insulin, and syringe pump for continuous subcutaneous insulin infusion (CSII). We constructed a predictive model for T1D patients using disease names, medical practices, and medications as explanatory variables. The predictive model was applied to patients of test group (validation data), and performances of candidate case definitions were evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>As a result of performance evaluation, the sensitivity of the confirmed disease name of T1D was 32.9 (95% CI: 28.4, 37.2), and positive predictive value (PPV) was 33.3 (95% CI: 38.0, 38.4). By using the case definition of both the confirmed diagnosis of T1D and either of the claims code of the two insulin treatment methods (i.e., syringe pump for CSII and insulin needles), PPV improved to 90.2 (95% CI: 85.2, 94.4).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We have established a case definition with high PPV, and the case definition can be used for precisely detecting T1D patients from claims data in Japan.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-021-01422-z","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T17:04:01Z","timestamp":1613063041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Performance evaluation of case definitions of type 1 diabetes for health insurance claims data in Japan"],"prefix":"10.1186","volume":"21","author":[{"given":"Tasuku","family":"Okui","sequence":"first","affiliation":[]},{"given":"Chinatsu","family":"Nojiri","sequence":"additional","affiliation":[]},{"given":"Shinichiro","family":"Kimura","sequence":"additional","affiliation":[]},{"given":"Kentaro","family":"Abe","sequence":"additional","affiliation":[]},{"given":"Sayaka","family":"Maeno","sequence":"additional","affiliation":[]},{"given":"Masae","family":"Minami","sequence":"additional","affiliation":[]},{"given":"Yasutaka","family":"Maeda","sequence":"additional","affiliation":[]},{"given":"Naoko","family":"Tajima","sequence":"additional","affiliation":[]},{"given":"Tomoyuki","family":"Kawamura","sequence":"additional","affiliation":[]},{"given":"Naoki","family":"Nakashima","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"issue":"6","key":"1422_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jcjd.2016.05.002","volume":"40","author":"S Butalia","year":"2016","unstructured":"Butalia S, Kaplan GG, Khokhar B, Rabi DM. Environmental risk factors and type 1 diabetes: past, present, and future. Can J Diabetes. 2016;40(6):586\u201393.","journal-title":"Can J Diabetes"},{"issue":"9911","key":"1422_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383(9911):69\u201382.","journal-title":"Lancet"},{"issue":"2","key":"1422_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s13300-019-00743-7","volume":"11","author":"A Jane\u017e","year":"2020","unstructured":"Jane\u017e A, Guja C, Mitrakou A, et al. Insulin therapy in adults with type 1 diabetes mellitus: a narrative review. Diabetes Ther. 2020;11(2):387\u2013409.","journal-title":"Diabetes Ther"},{"issue":"7","key":"1422_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/dme.13295","volume":"34","author":"Y Onda","year":"2017","unstructured":"Onda Y, Sugihara S, Ogata T, et al. Incidence and prevalence of childhood-onset Type 1 diabetes in Japan: the T1D study. Diabet Med. 2017;34(7):909\u201315.","journal-title":"Diabet Med"},{"issue":"5","key":"1422_CR5","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s00125-006-0213-8","volume":"49","author":"E Kawasaki","year":"2006","unstructured":"Kawasaki E, Matsuura N, Eguchi K. Type 1 diabetes in Japan. Diabetologia. 2006;49(5):828\u201336.","journal-title":"Diabetologia"},{"issue":"1","key":"1422_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40801-017-0126-5","volume":"5","author":"J Mahlich","year":"2018","unstructured":"Mahlich J, Tsukazawa S, Wiegand F. Estimating prevalence and healthcare utilization for treatment-resistant depression in japan: a retrospective claims database study. Drugs Real World Outcomes. 2018;5(1):35\u201343.","journal-title":"Drugs Real World Outcomes"},{"issue":"3","key":"1422_CR7","doi-asserted-by":"publisher","first-page":"e025806","DOI":"10.1136\/bmjopen-2018-025806","volume":"9","author":"R Nishimura","year":"2019","unstructured":"Nishimura R, Kato H, Kisanuki K, et al. Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study. BMJ Open. 2019;9(3):e025806.","journal-title":"BMJ Open"},{"issue":"11","key":"1422_CR8","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.clinthera.2019.08.015","volume":"41","author":"K Sato","year":"2019","unstructured":"Sato K, Ohno T, Ishii T, Ito C, Kaise T. The prevalence, characteristics, and patient burden of severe asthma determined by using a Japan health care claims database. Clin Ther. 2019;41(11):2239\u201351.","journal-title":"Clin Ther"},{"issue":"2","key":"1422_CR9","doi-asserted-by":"publisher","first-page":"e007378","DOI":"10.1161\/JAHA.117.007378","volume":"7","author":"A Khan","year":"2018","unstructured":"Khan A, Ramsey K, Ballard C, et al. Limited accuracy of administrative data for the identification and classification of adult congenital heart disease. J Am Heart Assoc. 2018;7(2):e007378.","journal-title":"J Am Heart Assoc"},{"key":"1422_CR10","doi-asserted-by":"publisher","first-page":"117822261668588","DOI":"10.1177\/1178222616685880","volume":"9","author":"J Oake","year":"2017","unstructured":"Oake J, Aref-Eshghi E, Godwin M, et al. Using electronic medical record to identify patients with dyslipidemia in primary care settings: international classification of disease code matters from one region to a national database. Biomed Inform Insights. 2017;9:1178222616685880.","journal-title":"Biomed Inform Insights"},{"issue":"8","key":"1422_CR11","doi-asserted-by":"publisher","first-page":"e008424","DOI":"10.1136\/bmjopen-2015-008424","volume":"5","author":"MS van Mourik","year":"2015","unstructured":"van Mourik MS, van Duijn PJ, Moons KG, Bonten MJ, Lee GM. Accuracy of administrative data for surveillance of healthcare-associated infections: a systematic review. BMJ Open. 2015;5(8):e008424.","journal-title":"BMJ Open"},{"issue":"5","key":"1422_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/jgh.14855","volume":"35","author":"CK Lee","year":"2020","unstructured":"Lee CK, Ha HJ, Oh SJ, et al. Nationwide validation study of diagnostic algorithms for inflammatory bowel disease in Korean National Health Insurance Service database. J Gastroenterol Hepatol. 2020;35(5):760\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"1422_CR13","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1161\/HYPERTENSIONAHA.109.139279","volume":"54","author":"H Quan","year":"2009","unstructured":"Quan H, Khan N, Hemmelgarn BR, et al. Validation of a case definition to define hypertension using administrative data. Hypertension. 2009;54(6):1423\u20138.","journal-title":"Hypertension"},{"issue":"e2","key":"1422_CR14","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1136\/amiajnl-2013-001952","volume":"20","author":"RL Richesson","year":"2013","unstructured":"Richesson RL, Rusincovitch SA, Wixted D, et al. A comparison of phenotype definitions for diabetes mellitus. J Am Med Inform Assoc. 2013;20(e2):e319\u201326.","journal-title":"J Am Med Inform Assoc"},{"key":"1422_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cmpb.2017.09.009","volume":"152","author":"S Esteban","year":"2017","unstructured":"Esteban S, Rodr\u00edguez Tablado M, Peper FE, et al. Development and validation of various phenotyping algorithms for Diabetes Mellitus using data from electronic health records. Comput Methods Programs Biomed. 2017;152:53\u201370.","journal-title":"Comput Methods Programs Biomed"},{"issue":"2","key":"1422_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.diabres.2010.03.007","volume":"89","author":"G Chen","year":"2010","unstructured":"Chen G, Khan N, Walker R, Quan H. Validating ICD coding algorithms for diabetes mellitus from administrative data. Diabetes Res Clin Pract. 2010;89(2):189\u201395.","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"1422_CR17","doi-asserted-by":"publisher","first-page":"e009952","DOI":"10.1136\/bmjopen-2015-009952","volume":"6","author":"B Khokhar","year":"2016","unstructured":"Khokhar B, Jette N, Metcalfe A, et al. Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations. BMJ Open. 2016;6(8):e009952.","journal-title":"BMJ Open"},{"key":"1422_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijmedinf.2016.09.014","volume":"97","author":"T Zheng","year":"2017","unstructured":"Zheng T, Xie W, Xu L, et al. A machine learning-based framework to identify type 2 diabetes through electronic health records. Int J Med Inform. 2017;97:120\u20137.","journal-title":"Int J Med Inform"},{"issue":"4","key":"1422_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1177\/1932296816681584","volume":"11","author":"R Kagawa","year":"2017","unstructured":"Kagawa R, Kawazoe Y, Ida Y, et al. Development of type 2 diabetes mellitus phenotyping framework using expert knowledge and machine learning approach. J Diabetes Sci Technol. 2017;11(4):791\u20139.","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"1422_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.2337\/dc12-0964","volume":"36","author":"M Klompas","year":"2013","unstructured":"Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R. Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Diabetes Care. 2013;36(4):914\u201321.","journal-title":"Diabetes Care"},{"key":"1422_CR21","doi-asserted-by":"publisher","first-page":"103258","DOI":"10.1016\/j.jbi.2019.103258","volume":"97","author":"JN Swerdel","year":"2019","unstructured":"Swerdel JN, Hripcsak G, Ryan PB. PheValuator: development and evaluation of a phenotype algorithm evaluator. J Biomed Inform. 2019;97:103258.","journal-title":"J Biomed Inform"},{"issue":"6","key":"1422_CR22","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/jpc.14480","volume":"55","author":"LJ Ross","year":"2019","unstructured":"Ross LJ, Neville KA. Continuous subcutaneous insulin infusion versus multiple daily injections for type 1 diabetes. J Paediatr Child Health. 2019;55(6):718\u201322.","journal-title":"J Paediatr Child Health"},{"key":"1422_CR23","doi-asserted-by":"publisher","first-page":"1473160","DOI":"10.1155\/2018\/1473160","volume":"2018","author":"B Matejko","year":"2018","unstructured":"Matejko B, Kuku\u0142ka A, Kie\u0107-Wilk B, St\u0105p\u00f3r A, Klupa T, Malecki MT. Basal insulin dose in adults with type 1 diabetes mellitus on insulin pumps in real-life clinical practice: a single-center experience. Adv Med. 2018;2018:1473160.","journal-title":"Adv Med"},{"issue":"5","key":"1422_CR24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1177\/1932296817697330","volume":"11","author":"T Murata","year":"2017","unstructured":"Murata T, Aoki Y, Kato Y, et al. The percentage of continuous subcutaneous insulin infusion usage among adult type 1 diabetes mellitus patients in Japan: a cross-sectional study at national hospital organization hospitals. J Diabetes Sci Technol. 2017;11(5):1055\u20136.","journal-title":"J Diabetes Sci Technol"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-021-01422-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12911-021-01422-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-021-01422-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T17:10:48Z","timestamp":1613063448000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-021-01422-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1422"],"URL":"https:\/\/doi.org\/10.1186\/s12911-021-01422-z","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"22 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and was approved by the ethical committees of Faculty of Medicine of the Kyushu University (Number 2019\u2013587). Also, we used existing and de-identified clinical data of a hospital, and obtaining informed consents from all participants is difficult. In this case, informed consent from all the participants are not essential according to Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan (). In addition, need of informed consent from participants was waived by the ethics committee of Faculty of Medicine of the Kyushu University. Instead, we made an opportunity for declining participation in this study by disclosing information about this study in our homepage ().","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}